Advertisement

Indian Journal of Surgical Oncology

, Volume 10, Supplement 1, pp 37–40 | Cite as

Management of Peritoneal Surface Malignancies in Pakistan

  • Raza SayyedEmail author
  • PSM Pakistan Working Group
Review Article
  • 30 Downloads

Abstract

This article looks at the current status and evolution of management of peritoneal surface malignancies in Pakistan. A brief overview of health-care infrastructure in the country and an outline of the centers actively involved in the management of PSM are provided.

Keywords

Peritoneal Surface Malignancies Cytoreductive Surgery HIPEC 

Notes

PSM Pakistan Working Group

• Dow University of Health Sciences, Karachi Pakistan

 – Dr. Samiullah Khan Niazi

• Jinnah Postgraduate Medical Centre, Karachi Pakistan

 – Prof Shamim Qureshi

 – Dr. Dileep Kumar

 – Dr. Naeem Khan

 – Dr. Mariyah Anwer

• Patel Hospital, Karachi Pakistan

 – Dr. Raza Hasnain Sayyed

• Shifa International Hospital, Islamabad Pakistan

 – Dr. Hadi Mohammad Khan

• The Aga Khan University, Karachi Pakistan

 – Dr. K. M. Inam Pal

• University of Lahore, Lahore Pakistan

 – Prof Muhammad Arshad Cheema

 – Prof Abul Fazl Ali Khan

References

  1. 1.
    Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN (2000 Jan 15) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363CrossRefPubMedGoogle Scholar
  2. 2.
    Sugarbaker PH (2011) Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? Am J Surg 201:157–159.  https://doi.org/10.1016/j.amjsurg.2010.04.010 CrossRefPubMedGoogle Scholar
  3. 3.
    Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28(1):63–68CrossRefGoogle Scholar
  4. 4.
    Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22(16):3284–3292.  https://doi.org/10.1200/JCO.2004.10.012 CrossRefGoogle Scholar
  5. 5.
    Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg 249(6):900–907CrossRefPubMedGoogle Scholar
  6. 6.
    Moran BJ (2006) Decision-making and technical factors account for the learning curve in complex surgery. J Pub Health 28:375–378.  https://doi.org/10.1093/pubmed/fdl048 CrossRefGoogle Scholar
  7. 7.
    Kusamura S, Baratti D, Deraco M (2012) Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 255:348–356.  https://doi.org/10.1097/SLA.0b013e3182436c28 CrossRefPubMedGoogle Scholar
  8. 8.
    Shannon NB, Tan GHC, Chia CS, Soo KC, Teo MCC (2018) Biphasic learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:technical competence and refinement of patient selection. Pleura and Peritoneum [Internet]. [cited 2018 Nov 20];0(0). Available from: https://www.degruyter.com/view/j/pp.ahead-of-print/pp-2018-0122/pp-2018-0122.xml
  9. 9.
    Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA (2015) Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol 22:1673–1679.  https://doi.org/10.1245/s10434-014-4111-x CrossRefPubMedGoogle Scholar
  10. 10.
    Spiliotis J, Halkia E, de Bree E (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives. Curr Oncol 23(3):e266–e275CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sayyed R, Niazi SK, Siddiqui T A case for setting-up dedicated peritoneal surface malignancy centers in Pakistan. J Pak Med Assoc 67(11):1780–1Google Scholar
  12. 12.
    Health Systems Profile- Pakistan (2007) World Health Organization. Regional Health Systems Observatory- EMROGoogle Scholar
  13. 13.
    Ghaffar A, Kazi BM, Salman M (2000) Health care system in transition. Pakistan, part 1. An overview of the health care system in Pakistan. J Public Health Med 22(1):38–42CrossRefPubMedGoogle Scholar
  14. 14.
    Kurji Z, Premani ZS, Mithani Y (2016) Analysis of the health care system of Pakistan: lessons learnt and way forward. J Ayub Med Coll Abbottabad 28(3):601–604PubMedGoogle Scholar
  15. 15.
    Pakistan health profile (2015) World Health Organization. Regional Office for the Eastern Mediterranean, CairoGoogle Scholar
  16. 16.
    European School of Peritoneal Surface Oncology (ESPSO): ESSO [Internet]. [cited 2018 Nov 20]. Available from: https://www.essoweb.org/school-of-peritoneal-surface-oncology-es/
  17. 17.
    The Peritoneal Surface Oncology Group International (PSOGI) [Internet]. PSOGI. [cited 2018 Nov 20]. Available from: http://www.psogi.com/

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Peritoneal Surface Malignancies ServicePatel HospitalKarachiPakistan

Personalised recommendations